A phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).

被引:0
|
作者
Sabichi, A. L. [1 ]
Kies, M. S. [1 ]
Glisson, B. S. [1 ]
Lu, C. [1 ]
Ginsberg, L. E. [1 ]
Bartos, C. I. [1 ]
Feng, L. [1 ]
Tran, H. T. [1 ]
Lippman, S. M. [1 ]
Blumenschein, G. R., Jr. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5532
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Final results of a phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).
    Blumenschein, George R.
    Glisson, Bonnie S.
    Lu, Charles
    Sabichi, Anita Lyn
    Ginsberg, Lawrence E.
    Bartos, Claudia I.
    Feng, Lei
    Tran, Hai T.
    El-Naggar, Adel K.
    Lippman, Scott Michael
    Kies, Merrill S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
    Hitt, R.
    Irigoyen, A.
    Nunez, J.
    Grau, J.
    Garcia Saenz, J.
    Pastor, M.
    Jara, C.
    Garcia Giron, C.
    Hidalgo, M.
    Cruz Hernandez, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    [J]. CANCER, 2001, 91 (07) : 1316 - 1323
  • [4] A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer
    Ferrari, Daris
    Fiore, Jessica
    Codeca, Carla
    Di Maria, Giuseppe
    Bozzoni, Samuela
    Bordin, Veronica
    Caldiera, Sarah
    Luciani, Andrea
    Zonato, Sabrina
    Floriani, Irene
    Foa, Paolo
    [J]. ANTI-CANCER DRUGS, 2009, 20 (03) : 185 - 190
  • [5] Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: A phase II study
    Fountzilas, G
    Athanassiadis, A
    Samantas, E
    Skarlos, D
    KalogeraFountzila, A
    Nikolaou, A
    Bacoyiannis, H
    Stathopoulos, G
    Kosmidis, P
    Daniilidis, J
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (01) : S65 - S67
  • [6] Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group phase II study
    Samlowski, Wolfram E.
    Moon, James
    Kuebler, J. Philip
    Nichols, Craig R.
    Gandara, David R.
    Ozer, Howard
    Williamson, Stephen K.
    Atkins, James N.
    Schuller, David E.
    Ensley, John F.
    [J]. CANCER INVESTIGATION, 2007, 25 (03) : 182 - 188
  • [7] Paclitaxel and carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. A phase II study.
    Hiller, S
    Mergenthaler, HG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 507S - 507S
  • [8] Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Degardin, M
    Bastit, P
    Rolland, F
    Armand, JP
    Chevallier, B
    VanGlabbeke, M
    Boudillet, J
    Tresca, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 843 - 843
  • [9] Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck
    Pivot, X
    Cals, L
    Cupissol, D
    Guardiola, E
    Tchiknavorian, X
    Guerrier, P
    Merad, L
    Wendling, JL
    Barnouin, L
    Savary, J
    Thyss, A
    Schneider, M
    [J]. ONCOLOGY, 2001, 60 (01) : 66 - 71
  • [10] A phase II trial of biweekly gemcitabine and paclitaxel (GEMTAX) combination in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group study
    Bickel, K. E.
    Worden, F. P.
    Moon, J.
    Kucuk, O.
    Wheeler, R. H.
    Clark, J.
    Wolf, G. T.
    Urba, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)